Published in Br J Haematol on March 01, 1989
Haematology. Postgrad Med J (1990) 0.75
Long-term survival in chronic granulocytic leukaemia. Br J Haematol (1989) 0.75
Complete remission duration and long-term survivors (LTS) in chronic myelogenous leukaemia (CML): a theoretical approach to a clinical decision. Br J Haematol (1990) 0.75
X-linked Wiskott-Aldrich syndrome in a girl. N Engl J Med (1998) 3.45
Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients. J Clin Microbiol (2004) 2.54
Small supernumerary marker chromosomes--progress towards a genotype-phenotype correlation. Cytogenet Genome Res (2006) 2.52
A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia. Blood (2001) 2.50
MDR1 gene expression and treatment outcome in acute myeloid leukemia. J Natl Cancer Inst (1991) 2.50
Aneurysmal bone cyst. A population based epidemiologic study and literature review. Clin Orthop Relat Res (1999) 2.22
Comparative sequence analysis of the hexon gene in the entire spectrum of human adenovirus serotypes: phylogenetic, taxonomic, and clinical implications. J Virol (2005) 1.85
The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia. Proc Natl Acad Sci U S A (2001) 1.82
Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23). Oncogene (1997) 1.80
Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients. Am J Surg Pathol (2001) 1.75
Nonradioactive labeling of probe with digoxigenin by polymerase chain reaction. Anal Biochem (1990) 1.70
Mutational analysis of the SOX9 gene in campomelic dysplasia and autosomal sex reversal: lack of genotype/phenotype correlations. Hum Mol Genet (1997) 1.60
Detection and monitoring of virus infections by real-time PCR. Mol Aspects Med (2006) 1.54
The MLL recombinome of acute leukemias. Leukemia (2006) 1.51
Origins of "late" relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes. Blood (2001) 1.50
Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia. Leukemia (2008) 1.48
Lack of DNA synthesis among CD34+ cells in cord blood and in cytokine-mobilized blood. Br J Haematol (1996) 1.48
Noncontiguous spinal metastases and plasmocytomas should be operated on through a single posterior midline approach, and circumferential decompression should be performed with individualized reconstruction. Acta Neurochir (Wien) (2000) 1.48
The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): does it prove true for the M3-variant? Cytometry (2000) 1.44
Novel CBF beta-MYH11 fusion transcripts and alternative splicing in acute myeloid leukemia with inversion of chromosome 16. Blood (1995) 1.38
Detection of gene expression by PCR amplification of RNA derived from frozen heparinized whole blood. Nucleic Acids Res (1991) 1.33
Nineteen cases of the t(1;22)(p13;q13) acute megakaryblastic leukaemia of infants/children and a review of 39 cases: report from a t(1;22) study group. Leukemia (2000) 1.28
CREBBP HAT domain mutations prevail in relapse cases of high hyperdiploid childhood acute lymphoblastic leukemia. Leukemia (2012) 1.18
Multiplex reverse transcriptase-polymerase chain reaction screening in childhood acute myeloblastic leukemia. Blood (2001) 1.14
Mapping of the breakpoints on the short arm of chromosome 17 in neoplasms with an i(17q). Genes Chromosomes Cancer (1999) 1.10
Phenotypic and genotypic heterogeneity in infant acute leukemia. II. Acute nonlymphoblastic leukemia. Leukemia (1989) 1.10
The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q. Proc Natl Acad Sci U S A (2000) 1.09
Molecular detection and quantitative analysis of the entire spectrum of human adenoviruses by a two-reaction real-time PCR assay. J Clin Microbiol (2005) 1.09
Species-specific identification of a wide range of clinically relevant fungal pathogens by use of Luminex xMAP technology. J Clin Microbiol (2009) 1.08
Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantation. Eur J Clin Invest (2008) 1.08
The RSD code: proposal for a nomenclature of allelic configurations in STR-PCR-based chimerism testing after allogeneic stem cell transplantation. Leukemia (2006) 1.08
Detection of tumour cells in peripheral blood and bone marrow from Ewing tumour patients by RT-PCR. Int J Cancer (1995) 1.08
Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression. Blood (1995) 1.07
Hematologic malignancies with t(4;11)(q21;q23)--a cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases. European 11q23 Workshop participants. Leukemia (1998) 1.07
Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma. Blood (1998) 1.04
The translocation t(1;22)(p13;q13) is a nonrandom marker specifically associated with acute megakaryocytic leukemia in young children. Blood (1992) 1.04
Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL. Oncogene (2001) 1.04
Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse. Leukemia (2004) 1.02
Induction of apoptosis by proteasome inhibitors in B-CLL cells is associated with downregulation of CD23 and inactivation of Notch2. Leukemia (2005) 1.01
Sporadic hypercalcitoninemia: clinical and therapeutic consequences. Endocr Relat Cancer (2008) 1.01
Deletion mapping on chromosome 10p and definition of a critical region for the second DiGeorge syndrome locus (DGS2). Eur J Hum Genet (1998) 1.00
Quantitative monitoring of BCR/ABL1 mutants for surveillance of subclone-evolution, -expansion, and -depletion in chronic myeloid leukaemia. Eur J Cancer (2011) 1.00
Pre-emptive treatment of CMV DNAemia in paediatric stem cell transplantation: the impact of recipient and donor CMV serostatus on the incidence of CMV disease and CMV-related mortality. Bone Marrow Transplant (2003) 1.00
Evaluation of antileukaemic effects of rapamycin in patients with imatinib-resistant chronic myeloid leukaemia. Eur J Clin Invest (2008) 0.99
Methylation changes in promoter and enhancer regions of the WT1 gene in Wilms' tumours. Cancer Lett (2001) 0.99
Spontaneous remission of acute myeloid leukemia after infection and blood transfusion associated with hypergammaglobulinaemia. Ann Hematol (1996) 0.98
Detection of numerical and structural chromosome abnormalities in pediatric germ cell tumors by means of interphase cytogenetics. Genes Chromosomes Cancer (1994) 0.98
Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors. Bone Marrow Transplant (1998) 0.97
In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. Leukemia (2004) 0.97
Successful carboxypeptidase G2 rescue in delayed methotrexate elimination due to renal failure. Pediatr Hematol Oncol (1996) 0.96
C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin. Am J Surg Pathol (1998) 0.95
RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications. Leukemia (2004) 0.95
PAX5/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13). Leukemia (2003) 0.95
Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. Surgery (1999) 0.94
Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy. Eur J Clin Invest (2007) 0.94
Identification of fungal species by fragment length analysis of the internally transcribed spacer 2 region. Eur J Clin Microbiol Infect Dis (2008) 0.93
Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment. Leukemia (1999) 0.93
Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1+ acute lymphoblastic leukemia: an interphase FISH analysis. Leukemia (2004) 0.93
Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: a comparison between cytogenetic and polymerase chain reaction analyses. Leukemia (1993) 0.92
Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation. Leukemia (2011) 0.92
Constitutional interstitial deletion of 11p11 and pericentric inversion of chromosome 9 in a patient with Wiedemann-Beckwith syndrome and hepatoblastoma. Cancer Genet Cytogenet (1986) 0.91
High-resolution FISH of the entire integrated Epstein-Barr virus genome on extended human DNA. Cytogenet Cell Genet (1996) 0.91
Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS). Leukemia (1999) 0.90
Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in immunocompromised pediatric patients. Leukemia (2010) 0.90
Phenotypic and genotypic heterogeneity in infant acute leukemia. I. Acute lymphoblastic leukemia. Leukemia (1989) 0.89
Parental origin of chromosomes involved in the translocation t(9;22). Nature (1992) 0.89
Debate round-table. Appropriate controls for RT-PCR. Leukemia (1997) 0.89
Evaluation of the fragile X (FRAXA) syndrome with methylation-sensitive PCR. Hum Genet (2001) 0.89
An ins(X;11)(q24;q23) fuses the MLL and the Septin 6/KIAA0128 gene in an infant with AML-M2. Genes Chromosomes Cancer (2001) 0.88
Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia. Leukemia (1997) 0.88
Platelet-associated immunoglobulins IgG, IgM, IgA and complement C3 in immune and nonimmune thrombocytopenic disorders. Am J Hematol (1986) 0.88
Fresh frozen plasma contains free asparagine and may replace the plasma asparagine pool during L-asparaginase therapy. Leukemia (2007) 0.88
Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome. Br J Cancer (2006) 0.87
Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejection. Leukemia (2003) 0.86
Post-transplant acute myeloid leukemia (PT-AML). Leukemia (1999) 0.86
Reconstitution of catecholamine-sensitive adenylate cyclase activity: interaction of components following cell-cell and membrane-cell fusion. J Cyclic Nucleotide Res (1977) 0.85
Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the "BFM Family" Cooperative Group. Med Pediatr Oncol (1992) 0.85
Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurements. Leukemia (2007) 0.85
Promoter-specific methylation and expression alterations of igf2 and h19 are involved in human hepatoblastoma. Int J Cancer (1998) 0.85
Prediction of the response to chemotherapy in acute leukemia by a short-term test in vitro. Cancer (1984) 0.85
Prognostic significance of myeloid-associated antigen expression on blast cells in children with acute lymphoblastic leukemia. The Austrian Pediatric Oncology Group. Med Pediatr Oncol (1993) 0.85
beta-Adrenergic responsiveness of human peripheral lymphocytes after mitogenic transformation with phytohemagglutinin. Biochem Pharmacol (1983) 0.84
Distinct fluctuations of ammonia levels during asparaginase therapy for childhood acute leukemia. Pediatr Blood Cancer (2007) 0.84
Silencing of ETV6/RUNX1 abrogates PI3K/AKT/mTOR signaling and impairs reconstitution of leukemia in xenografts. Leukemia (2011) 0.84
Quantitative monitoring of cell clones carrying point mutations in the BCR-ABL tyrosine kinase domain by ligation-dependent polymerase chain reaction (LD-PCR). Leukemia (2008) 0.84
CBFB/MYH11 fusion in a patient with AML-M4Eo and cytogenetically normal chromosomes 16. Genes Chromosomes Cancer (2000) 0.84
Interference of dye-associated fluorescence signals with quantitative analysis of chimerism by capillary electrophoresis. Leukemia (2003) 0.83
Drug resistance factors in acute myeloid leukemia: a comparative analysis. Leukemia (2000) 0.83